Cytokine response in inflammatory myopathies.
After background information about pathologic findings, this review focuses on the cytokine response in the pathogenesis of polymyositis and dermatomyositis. Cytokines are important mediators of the immune response and play a key role in these diseases by acting on inflammatory immune cells, muscle cells, and vessel cells. Various cytokines are found in myositis samples, in particular interleukin-1 and tumor necrosis factor-alpha, which are associated with the migration, differentiation, and maturation of inflammatory cells. Recent advances indicate that the muscle cell itself could participate in the inflammatory process. Cytokines promote changes in muscle metabolism resulting in a self-sustaining inflammatory response. Accordingly, cytokines may represent new targets for therapies.
Tournadre
Anne
A
Clinical Immunology Unit, Department of Immunology and Rheumatology, Hospital Edouard Herriot, Lyon Cedex 03, France.
Miossec
Pierre
P
D016207:Cytokines / Q000037:antagonists & inhibitors / Q000276:immunology*; D042783:Endothelial Cells / Q000276:immunology; D006801:Humans; D032342:Muscle Cells / Q000276:immunology; D009220:Myositis / Q000188:drug therapy / Q000276:immunology* / Q000503:physiopathology
D016207:Cytokines
Hum Pathol. 1989 Mar;20(3):224-31
2470663
J Neuroimmunol. 1995 Dec;63(1):9-16
8557829
Clin Exp Immunol. 1994 Jan;95(1):166-72
7507012
J Neuroimmunol. 2003 Apr;137(1-2):125-33
12667656
J Neurol Sci. 1991 Feb;101(2):193-7
1903437
Clin Immunol. 1999 Aug;92(2):161-9
10444360
Arthritis Rheum. 1997 May;40(5):865-74
9153548
Lancet. 2003 Sep 20;362(9388):971-82
14511932
Int Immunol. 2000 Sep;12(9):1329-35
10967028
Neuromuscul Disord. 2004 May;14(5):337-45
15099594
Arthritis Rheum. 2005 Aug;52(8):2263-71
16052582
Clin Exp Immunol. 1998 Sep;113(3):407-14
9737670
J Rheumatol. 2000 Apr;27(4):940-8
10782820
Ann Rheum Dis. 2005 Sep;64(9):1257-62
15731288
Proc Assoc Am Physicians. 1997 May;109(3):275-85
9154644
J Exp Med. 2002 Sep 16;196(6):781-91
12235211
J Exp Med. 2005 Feb 21;201(4):591-601
15728237
Neuromuscul Disord. 1999 Jun;9(4):239-46
10399751
J Clin Invest. 1992 Dec;90(6):2333-9
1281830
Clin Sci (Lond). 1995 Oct;89(4):431-9
7493444
Curr Opin Rheumatol. 2003 Nov;15(6):708-13
14569199
Proc Natl Acad Sci U S A. 2000 Aug 1;97(16):9209-14
10922072
Neuropathol Appl Neurobiol. 2005 Feb;31(1):70-9
15634233
Trends Immunol. 2005 Jul;26(7):373-80
15922662
Clin Immunol. 2000 Feb;94(2):99-104
10637094
J Immunol. 1998 Jul 1;161(1):409-14
9647250
Arthritis Rheum. 2004 Jan;50(1):199-208
14730617
Nat Immunol. 2005 Nov;6(11):1123-32
16200070
Int Immunol. 1998 Mar;10(3):267-73
9576614
J Rheumatol. 2006 May;33(5):1021-6
16541475
Arthritis Rheum. 2003 Mar;48(3):594-601
12632409
J Immunol. 2001 Nov 15;167(10):6015-20
11698482
Nat Immunol. 2005 Nov;6(11):1133-41
16200068
J Autoimmune Dis. 2006 Feb 20;3:2
16504012
J Neuropathol Exp Neurol. 1994 Jul;53(4):369-76
8021710
FASEB J. 2004 Feb;18(2):227-37
14769817
Arthritis Rheum. 2005 Jun;52(6):1824-35
15934115
Arthritis Rheum. 2005 Feb;52(2):601-7
15692974
J Neuropathol Exp Neurol. 1996 Mar;55(3):342-7
8786392
Arthritis Rheum. 2007 Feb;56(2):674-87
17265504
J Rheumatol. 2006 Sep;33(9):1802-4
16960940
Biochim Biophys Acta. 2005 Apr 15;1743(3):187-97
15843032
Ann Rheum Dis. 2006 Sep;65(9):1233-6
16476710
Neuropathol Appl Neurobiol. 1998 Feb;24(1):73-9
9549732